{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:11Z","timestamp":1788872411538,"version":"build-2803163510"},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4322,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Sanofi-Synthelabo, Germany"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress. Anxiety"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1002\/da.10099","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T17:52:08Z","timestamp":1068832328000},"page":"140-143","source":"Crossref","is-referenced-by-count":35,"title":["Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers"],"prefix":"10.1155","volume":"18","author":[{"given":"Peter","family":"Zwanzger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Eser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Baghai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Schule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"R\u00f6tzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,11,12]]},"reference":[{"key":"10.1002\/da.10099-BIB1|cit3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0006-3223(94)91188-6","article-title":"Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology","volume":"36","author":"Abelson","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.10099-BIB2|cit4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/ajp.151.2.261","article-title":"Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients","volume":"151","author":"Bradwejn","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.10099-BIB3|cit5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1176\/ajp.149.7.962","article-title":"Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings","volume":"149","author":"Bradwejn","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.10099-BIB4|cit6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(99)00188-2","article-title":"SPECT [I123] iomazenil measurement of the benzodiazepine receptor in panic disorder","volume":"47","author":"Bremner","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.10099-BIB5|cit7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-1781(87)90002-3","article-title":"Measurement of lactate-induced panic and anxiety","volume":"20","author":"Dillon","year":"1987","journal-title":"Psychiatry Res"},{"key":"10.1002\/da.10099-BIB6|cit8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archpsyc.58.6.556","article-title":"Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy","volume":"58","author":"Goddard","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.10099-BIB7|cit9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0006-3223(93)90010-B","article-title":"Valproate treatment of panic disorder and lactate induced panic attacks","volume":"33","author":"Keck","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.10099-BIB8|cit10","first-page":"485","article-title":"Influence of medication and family history on cortical GABA levels in panic disorder","volume":"51","author":"Goddard","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.10099-BIB9|cit11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0006-3223(02)01672-4","article-title":"Molecular targets in the treatment of anxiety","volume":"52","author":"Kent","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.10099-BIB10|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","article-title":"Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers","volume":"8","author":"Koszycki","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1002\/da.10099-BIB11|cit13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archpsyc.58.6.556","article-title":"Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy","volume":"58","author":"Krystal","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.10099-BIB12|cit14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archpsyc.55.8.715","article-title":"Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study","volume":"55","author":"Malizia","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.10099-BIB13|cit15","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1111\/j.1528-1157.1996.tb06038.x","article-title":"Update on the mechanism of action of antiepileptic drugs","volume":"37","author":"Meldrum","year":"1996","journal-title":"Epilepsia"},{"key":"10.1002\/da.10099-BIB14|cit16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008877-199903000-00002","article-title":"Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze","volume":"10","author":"Schmitt","year":"1999","journal-title":"Behav Pharmacol"},{"key":"10.1002\/da.10099-BIB15|cit17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0091-3057(94)90226-7","article-title":"Anxiolytic-like effect of the GABA-transaminase inhibitor vigabatrin (\u03b3-vinyl GABA) on rat exploratory activity","volume":"49","author":"Sherif","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1002\/da.10099-BIB16|cit18","first-page":"332","article-title":"Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder","volume":"22","author":"Shlik","year":"1997","journal-title":"J Psychiatry Neurosci"},{"key":"10.1002\/da.10099-BIB17|cit19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0893-133X(99)00115-3","article-title":"Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder","volume":"22","author":"Strohle","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.10099-BIB18|cit20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002130050201","article-title":"Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK- 4-induced panic attacks","volume":"129","author":"van Megen","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.10099-BIB19|cit21","first-page":"134","article-title":"Panic disorder: Treatment with valproate","volume":"55","author":"Woodman","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.10099-BIB20|cit22","first-page":"239","article-title":"Anxiolytic Effects of Vigabatrin in Panic Disorder","volume":"35","author":"Zwanzger","year":"2001a","journal-title":"J Clin Psychopharmacology"},{"key":"10.1002\/da.10099-BIB21|cit23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4088\/JCP.v62n0813d","article-title":"Tiagabine improves panic and agoraphobia in panic disorder patients","volume":"62","author":"Zwanzger","year":"2001b","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.10099-BIB22|cit24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(01)00266-4","article-title":"Vigabatrin decreases cholecystokinin tetrapeptide (CCK-4) induced panic in healthy volunteers","volume":"25","author":"Zwanzger","year":"2001c","journal-title":"Neuropsychopharmacology"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.10099","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/da.10099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T08:02:34Z","timestamp":1671523354000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.10099"}},"subtitle":["Brief Report: Effects of Tiagabine on CCK-4 Induced Panic"],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,11]]}},"URL":"https:\/\/doi.org\/10.1002\/da.10099","archive":["Portico"],"relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}